OneMedNet Restates Financials Due to Accountant Change
Ticker: ONMDW · Form: 8-K · Filed: Jun 4, 2024 · CIK: 1849380
Sentiment: bearish
Topics: accounting-restatement, auditor-change, financial-reporting
Related Tickers: ONMD
TL;DR
OneMedNet ditching its accountant means old financials are toast. Big audit headache incoming.
AI Summary
OneMedNet Corporation announced on June 3, 2024, that it will not rely on previously issued financial statements or related audit reports. This decision stems from the resignation of its certifying accountant, which necessitates a review of its financial reporting.
Why It Matters
This filing indicates potential issues with OneMedNet's past financial reporting, which could impact investor confidence and require significant effort to rectify.
Risk Assessment
Risk Level: high — The company is withdrawing reliance on previously issued financial statements, signaling significant accounting or reporting issues.
Key Players & Entities
- OneMedNet Corporation (company) — Registrant
- June 3, 2024 (date) — Date of earliest event reported
FAQ
What is the specific reason for the resignation of the certifying accountant?
The filing does not specify the exact reason for the resignation of the certifying accountant, only that it has occurred and impacts the reliance on previous financial statements.
Which previous financial statements are affected by this announcement?
The filing states that the company will not rely on 'previously issued financial statements or a related audit report or completed interim review', implying all such prior reports are now in question.
What is the timeline for issuing restated financial statements?
The filing does not provide a specific timeline for when restated financial statements will be issued.
Has OneMedNet identified any specific material weaknesses or errors in its past financial reporting?
The filing does not detail specific material weaknesses or errors but indicates that the change in accountant and the non-reliance on prior statements suggest potential issues.
What is the impact on the company's stock trading and reporting obligations?
The filing does not explicitly state the immediate impact on stock trading, but the need to restate financials typically leads to increased scrutiny and potential delays in future filings.
Filing Stats: 734 words · 3 min read · ~2 pages · Grade level 15.5 · Accepted 2024-06-04 16:15:30
Key Financial Figures
- $0.0001 — hich Registered Class A Common Stock, $0.0001 par value per share ONMD The Nasdaq
- $11.50 — A Common Stock at an exercise price of $11.50 per share ONMDW The Nasdaq Stock Ma
Filing Documents
- form8-k.htm (8-K) — 45KB
- 0001493152-24-022544.txt ( ) — 263KB
- onmd-20240603.xsd (EX-101.SCH) — 4KB
- onmd-20240603_def.xml (EX-101.DEF) — 26KB
- onmd-20240603_lab.xml (EX-101.LAB) — 36KB
- onmd-20240603_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ONEMEDNET CORPORATION Date: June 4, 2024 By: /s/ Aaron Green Name: Aaron Green Title: Chief Executive Officer